Salix Pharmaceuticals Ltd (SLXP)

172.81
0.16 0.09
NASDAQ : Health Care
Prev Close 172.65
Open 172.72
Day Low/High 172.71 / 172.96
52 Wk Low/High 86.00 / 172.98
Volume 4.30M
Avg Volume 3.38M
Exchange NASDAQ
Shares Outstanding 64.25M
Market Cap 11.10B
EPS -6.53
P/E Ratio N/A
Div & Yield N.A. (N.A)
European Stocks Are Higher Despite Downbeat Economic Data

European Stocks Are Higher Despite Downbeat Economic Data

European stocks rise on Friday, despite downbeat economic indicators for both the eurozone and the U.K.

Salix Pharmaceuticals And Cosmo Technologies Announce Termination Of Merger Agreement

Salix Pharmaceuticals And Cosmo Technologies Announce Termination Of Merger Agreement

Salix Pharmaceuticals, Ltd. (“Salix”) (NASDAQ: SLXP) and Cosmo Pharmaceuticals S.

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's Post-Market Leader Stock

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a post-market leader candidate

'Mad Money' Lightning Round: I'm Taking a Pass on New York Community Bancorp

'Mad Money' Lightning Round: I'm Taking a Pass on New York Community Bancorp

Cramer likes Salix Pharmaceuticals but would like Lazard better at a 3% yield.

Jim Cramer's 'Mad Money' Recap: Now Is Not the Time for Panic

Jim Cramer's 'Mad Money' Recap: Now Is Not the Time for Panic

While the markets may still have further to fall, investors need to be ready with their shopping list of stocks to buy when the bottom finally comes, Cramer says.

FDA Approves RELISTOR® Subcutaneous Injection For The Treatment Of Opioid-Induced Constipation In Patients With Chronic Non-cancer Pain

FDA Approves RELISTOR® Subcutaneous Injection For The Treatment Of Opioid-Induced Constipation In Patients With Chronic Non-cancer Pain

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals, Inc.

Triple As: Three Stocks to Consider

Be picky in this tough market.

Stocks, Analysts React to the Treasury Inversion Crackdown

Stocks, Analysts React to the Treasury Inversion Crackdown

The shares of a number of companies that have announced or been speculated as targets in tax inversion deals are falling after the U.S. Treasury last night issued new regulations...

Today Salix Pharmaceuticals (SLXP) Hits New Lifetime High

Today Salix Pharmaceuticals (SLXP) Hits New Lifetime High

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a new lifetime high candidate

September 23 Premarket Briefing: 10 Things You Should Know

September 23 Premarket Briefing: 10 Things You Should Know

U.S. stock futures point lower; the U.S. clamps down on corporate inversions; Allergan in advanced talks to buy Salix; Facebook to unveil a new advertising platform.

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's Post-Market Leader Stock

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a post-market leader candidate

Salix Announces FDA User Fee Goal Date Of February 28, 2015 For XIFAXAN® 550mg SNDA For Treatment Of Irritable Bowel Syndrome With Diarrhea

Salix Announces FDA User Fee Goal Date Of February 28, 2015 For XIFAXAN® 550mg SNDA For Treatment Of Irritable Bowel Syndrome With Diarrhea

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration (FDA) considers the Company’s August 29, 2014 resubmission of its supplemental New Drug Application (sNDA) for...

Why mid-cap stocks belong in your portfolio

Why mid-cap stocks belong in your portfolio

Here are some mid-cap stock picks that are worth a serious look.

Salix Secures Additional Intellectual Property Relating To Rifaximin

Salix Secures Additional Intellectual Property Relating To Rifaximin

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that Cipla Limited has granted Salix exclusive rights under certain patent applications in the “Rifaximin Complexes” patent family controlled by ...

3 Stocks Pushing The Health Care Sector Higher

3 Stocks Pushing The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

Today's Momo Momentum Stock To Watch: Salix Pharmaceuticals (SLXP)

Today's Momo Momentum Stock To Watch: Salix Pharmaceuticals (SLXP)

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a momo momentum candidate

Why Salix Pharmaceuticals (SLXP) Stock Is Higher Today

Why Salix Pharmaceuticals (SLXP) Stock Is Higher Today

Some of the top 20 investors are threatening to vote down a proposed deal to buy a unit of Cosmo Pharmaceuticals, and are pressing Salix to consider selling itself.

Strong On High Volume: Salix Pharmaceuticals (SLXP)

Strong On High Volume: Salix Pharmaceuticals (SLXP)

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a strong on high relative volume candidate

UCERIS® (budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-to-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA

UCERIS® (budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-to-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the FDA has granted tentative approval for UCERIS® (budesonide) rectal foam for the induction of remission in patients with active mild-to-moderate ...

What the tax inversion craze means for investors

What the tax inversion craze means for investors

Some investing ideas to profit from the tax inversion trend.

Off the Charts

Off the Charts

9/04/14: YY Inc. (YY) broke out above our consolidation level, triggering our entry price. Look for follow-through tomorrow.

Off the Charts

Off the Charts

Updating our current trade ideas.

Salix Submits Response To XIFAXAN® 550mg Complete Response Letter Regarding Repeat Treatment For Irritable Bowel Syndrome With Diarrhea

Salix Submits Response To XIFAXAN® 550mg Complete Response Letter Regarding Repeat Treatment For Irritable Bowel Syndrome With Diarrhea

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced today that on August 29, 2014, it submitted its response to the March 7, 2011, Food and Drug Administration (FDA) Complete Response Letter (CRL) regarding the ...

Perilous Reversal Stock: Salix Pharmaceuticals (SLXP)

Perilous Reversal Stock: Salix Pharmaceuticals (SLXP)

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "perilous reversal" (up big yesterday but down big today) candidate

Stock Market Today: Futures Slip as Markets Await More Fed Clarity

Stock Market Today: Futures Slip as Markets Await More Fed Clarity

Stock index futures are dipping slightly Wednesday after the sharp run-up of the last two sessions and ahead of the July FOMC minutes.

Aug. 20 Premarket Briefing: 10 Things You Should Know

Aug. 20 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are mixed; a report says Allergan approached Salix and at least one other company about a potential acquisition; Citigroup weighs sale of Japan unit.

Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today

Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today

It was reported that Allergan (AGN) approached the company and at least one other firm about a potential acquisition as it fights a hostile takeover from Valeant Pharmaceuticals (VRX).

Today's Unusual Social Activity Stock: Salix Pharmaceuticals (SLXP)

Today's Unusual Social Activity Stock: Salix Pharmaceuticals (SLXP)

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as an unusual social activity candidate

Salix Announces Early Termination Of HSR Waiting Period For Pending Transaction

Salix Announces Early Termination Of HSR Waiting Period For Pending Transaction

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that it has received notice of the early termination of the waiting period for U.

5 Stocks Rising on Unusual Volume

5 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.